These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10880786)

  • 1. Feasibility of using recipients of health promotional newsletters for post-marketing surveillance.
    Mead LA; Ford DE; Roht LH; Beach CL; Klag MJ
    J Clin Epidemiol; 2000 Jun; 53(6):653-60. PubMed ID: 10880786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study.
    Kjeldsen SE; Hedner T; Syvertsen JO; Lund-Johansen P; Hansson L; Lanke J; Lindholm LH; De Faire U; Dahlöf B; Karlberg BE;
    J Hypertens; 2002 Jun; 20(6):1231-7. PubMed ID: 12023696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.
    Hansson L; Hedner T; Lund-Johansen P; Kjeldsen SE; Lindholm LH; Syvertsen JO; Lanke J; de Faire U; Dahlöf B; Karlberg BE
    Lancet; 2000 Jul; 356(9227):359-65. PubMed ID: 10972367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Felodipine as an alternative to more expensive calcium antagonists in mild to moderate hypertension.
    Landry FJ; Horwhat JD; Tomich D; Pinski L
    South Med J; 1996 Jun; 89(6):573-7. PubMed ID: 8638195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual calcium-channel blocker therapy in the treatment of hypertension.
    Saseen JJ; Carter BL
    Ann Pharmacother; 1996; 30(7-8):802-10. PubMed ID: 8826565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
    Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after heart transplantation. Results of a prospective, randomized multicenter trail.
    Brozena SC; Johnson MR; Ventura H; Hobbs R; Miller L; Olivari MT; Clemson B; Bourge R; Quigg R; Mills RM; Naftel D
    J Am Coll Cardiol; 1996 Jun; 27(7):1707-12. PubMed ID: 8636558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium entry blockers for systemic hypertension.
    Moser M
    Am J Cardiol; 1987 Jan; 59(2):115A-121A. PubMed ID: 3028116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of blood pressure, cardiac output, peripheral resistance, and exercise performance to substitution of calcium blocker for beta-blocker plus thiazide diuretic therapy in patients with both systemic hypertension and mild stable angina.
    Kawanishi DT; Reid CL; Gonzales A; O'Rourke RA; Rahimtoola SH
    Circulation; 1989 Dec; 80(6 Suppl):IV162-70. PubMed ID: 2574640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.
    Goodman S; Hill C; Bata I; Fung A; Higginson L; Lam J; Massel D; McCans J; Nasmith J; Stanton E; Thompson C; Warnica W; Langer A
    Can J Cardiol; 1996 Nov; 12(11):1183-90. PubMed ID: 9191511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of hypertension: evidence from the Blood Pressure Lowering Treatment Trialists' Collaboration and from major clinical trials.
    Chalmers J; Arima H
    Pol Arch Med Wewn; 2009 Jun; 119(6):373-80. PubMed ID: 19694219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.
    Jo SH; Park SJ; Kim EJ; Kim SJ; Cho HJ; Song JM; Shin J; Park JJ; Shin JH; Han KR; Choi DJ
    Trials; 2018 Jun; 19(1):324. PubMed ID: 29925421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is diltiazem as effective as diuretics and beta-blockers in preventing complications from hypertension?
    Adelman A
    J Fam Pract; 2000 Nov; 49(11):1049. PubMed ID: 11093573
    [No Abstract]   [Full Text] [Related]  

  • 20. Calcium channel blockers suppress daily variations of blood pressure in hypertensive patients with end-stage renal diseases.
    Takenaka T; Sueyoshi K; Arai J; Watanabe Y; Takane H; Ohno Y; Suzuki H
    Clin Exp Hypertens; 2014; 36(2):78-82. PubMed ID: 24625333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.